13-23337467-G-C

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6

The NM_014363.6(SACS):​c.6409C>G​(p.Gln2137Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000328 in 1,613,478 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. Q2137Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000033 ( 0 hom. )

Consequence

SACS
NM_014363.6 missense

Scores

4
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 6.00

Publications

2 publications found
Variant links:
Genes affected
SACS (HGNC:10519): (sacsin molecular chaperone) This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that "the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins" (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
SACS Gene-Disease associations (from GenCC):
  • Charlevoix-Saguenay spastic ataxia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Myriad Women’s Health

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.16314736).
BP6
Variant 13-23337467-G-C is Benign according to our data. Variant chr13-23337467-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 649183. Variant chr13-23337467-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 649183. Variant chr13-23337467-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 649183. Variant chr13-23337467-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 649183. Variant chr13-23337467-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 649183. Variant chr13-23337467-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 649183. Variant chr13-23337467-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 649183. Variant chr13-23337467-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 649183. Variant chr13-23337467-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 649183. Variant chr13-23337467-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 649183. Variant chr13-23337467-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 649183. Variant chr13-23337467-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 649183. Variant chr13-23337467-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 649183. Variant chr13-23337467-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 649183. Variant chr13-23337467-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 649183. Variant chr13-23337467-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 649183. Variant chr13-23337467-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 649183.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SACSNM_014363.6 linkc.6409C>G p.Gln2137Glu missense_variant Exon 10 of 10 ENST00000382292.9 NP_055178.3 Q9NZJ4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SACSENST00000382292.9 linkc.6409C>G p.Gln2137Glu missense_variant Exon 10 of 10 5 NM_014363.6 ENSP00000371729.3 Q9NZJ4-1

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
152038
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000320
AC:
8
AN:
250294
AF XY:
0.00000738
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000707
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000328
AC:
48
AN:
1461440
Hom.:
0
Cov.:
37
AF XY:
0.0000316
AC XY:
23
AN XY:
726994
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33456
American (AMR)
AF:
0.0000224
AC:
1
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26112
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39686
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86188
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53372
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000396
AC:
44
AN:
1111788
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
152038
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74274
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41400
American (AMR)
AF:
0.00
AC:
0
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10582
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
67990
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000675
Hom.:
0
Bravo
AF:
0.0000491
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000330
AC:
4
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Charlevoix-Saguenay spastic ataxia Uncertain:2
Jan 27, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 22, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Jun 22, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.6409C>G (p.Q2137E) alteration is located in exon 10 (coding exon 9) of the SACS gene. This alteration results from a C to G substitution at nucleotide position 6409, causing the glutamine (Q) at amino acid position 2137 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Spastic paraplegia Benign:1
Dec 11, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
19
DANN
Benign
0.69
DEOGEN2
Benign
0.13
.;T
Eigen
Benign
-0.17
Eigen_PC
Benign
0.064
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.91
D;D
M_CAP
Benign
0.039
D
MetaRNN
Benign
0.16
T;T
MetaSVM
Benign
-0.53
T
MutationAssessor
Benign
1.1
.;L
PhyloP100
6.0
PrimateAI
Benign
0.45
T
PROVEAN
Benign
0.29
N;N
REVEL
Uncertain
0.34
Sift
Benign
0.84
T;T
Sift4G
Uncertain
0.050
T;D
Polyphen
0.023
.;B
Vest4
0.30
MVP
0.84
ClinPred
0.095
T
GERP RS
5.8
Varity_R
0.10
gMVP
0.39
Mutation Taster
=47/53
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201690040; hg19: chr13-23911606; COSMIC: COSV66543309; API